Treatment of ocular rosacea with 40 mg doxycycline in a slow release form;Behandlung der ophthalmo-rosazea mit 40 mg doxycyclin in teilretardierter form

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 11, 2011, Pages 904-907

  Pfeffer, Ines ^a   Borelli, Claudia ^a   Zierhut, Manfred ^a   Schaller, Martin ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Blepharitis; Doxycycline; Keratoconjunctivitis; Ocular rosacea; Rosacea

Indexed keywords

DOXYCYCLINE; ORAYCEA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG RELEASE; FEMALE; HUMAN; MALE; OCULAR ROSACEA; RETROSPECTIVE STUDY; ROSACEA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROSACEA;

EID: 84155168964     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07723.x     Document Type: Article

References (15)

1. Gauwerky K, Klövekorn W, Korting HC, Lehmann P, Meigel EM, Reinel D, Ruzicka T, Schaller M, Schöfer H, Tietze J. Rosacea. J Dtsch Dermatol Ges 2009;7(11):996-1003.
2. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology 1997;104(11):1863-7. (Pubitemid 28100343)
3. Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 1997;133(1):49-54. (Pubitemid 27044305)
4. Tanzi EL, Weinberg JM. The ocular manifestations of rosacea. Cutis 2001;68(2):112-4. (Pubitemid 33757342)
5. Plewig G. Akne und Rosazea. In: Braun-Falco O, Plewig G, Wolff H, Burgdorf W, Landthaler M (Hrsg): Dermatologie und Venerologie. 5. Auflage. Heidelberg: Springer Verlag, 2005.
6. Chalasani R, McNab A. Chronic lymphedema of the eyelid: case series. Orbit 2010;29(4):222-6.
7. Stone DU, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol 2004;15(6):499-502. (Pubitemid 39564471)
8. Iovieno A, Lambiase A, Micera A, Stampachiacchiere B, Sgrulletta R, Bonini S. In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. Eur J Ophthalmol 2009;19(5):708-16.
9. Baudouin C. A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol 2007;30(3):239-46.
10. Monk E, Shalita A, Siegel D. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res 2011;63(2):130-45.
11. Alvarenga LS, Mannis MJ. Ocular rosacea. Ocul Surf 2005;3(1):41-58. (Pubitemid 40347579)
12. Korting HC, Schöllmann C. Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol 2009;22(6):287-94.
13. Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea. Skinmed 2003;2(4):234-45.
14. Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol 2008;7(12):1149-52.
15. Del Rosso JQ. Anti-inflammatory dose doxycycline in the treatment of rosacea. J Drugs Dermatol 2009;8(7):664-8.